Megan Lerner to Receptor, Fibroblast Growth Factor, Type 2
This is a "connection" page, showing publications Megan Lerner has written about Receptor, Fibroblast Growth Factor, Type 2.
Connection Strength
0.152
-
Oncolytic potential of a novel KGFR tyrosine kinase inhibitor using a KGFR-selective breast cancer xenograft model. Anticancer Res. 2015 Jan; 35(1):47-52.
Score: 0.118
-
Influence of KGF on the progression of pancreatic cancer. Anticancer Res. 2009 Aug; 29(8):3417-20.
Score: 0.020
-
Antisense KGFR oligonucleotide inhibition of KGF-induced motility in breast cancer cells. Anticancer Res. 2003 Nov-Dec; 23(6C):4913-9.
Score: 0.014